Skip to product information
1 of 1

Dignitas Personae Explained: The Church's Teaching on Reproductive and Related Technologies - Paperback

Dignitas Personae Explained: The Church's Teaching on Reproductive and Related Technologies - Paperback

Regular price ¥255.81 CNY
Regular price Sale price ¥255.81 CNY
Sale Sold out
Taxes included. Shipping calculated at checkout.
By placing your order you agree to purchase from Global-e as the merchant of record, subject to Global-e’s Terms and Conditions and Privacy Policy, and share your information with annizon.com.

by John Fleming (Author)

Infertility and the suffering associated with it has always been a tragic part of the human experience. This is especially true today. Various medical remedies have been developed to deal with human infertility, with artificial reproductive technologies being widely used. There are many treatments for infertility which are approved by the Catholic Church. But the use of in vitro fertilisation (IVF) and related technologies have been condemned as contrary to the natural moral law. This book provides both an account of Church teaching and why the Church teaches what she does in a way that is accessible to the interested layperson. "Dr John Fleming reflects on, and amplifies, this new teaching document of the Church to make it all the more accessible to those who ought to benefit from it: not only those in the pew but also those in the laboratory who are not even religious." - Dr John Haas, from the Foreword. Dr John Fleming is an internationally renowned expert in bioethics with a past career in the mainstream media. He is Adjunct Professor of Bioethics at Southern Cross Bioethics Institute (Adelaide, South Australia), and a Corresponding Member of the Pontifical Academy for Life (Vatican). Dr Fleming was a foundation member of UNESCO's International Bioethics Committee which worked on producing international law in relation to human rights and the human genome.

Number of Pages: 94
Dimensions: 0.23 x 8.27 x 5.83 IN
Publication Date: October 01, 2012
View full details